Publisher Correction: defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from the EBMT global committee - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: EBMT Global Committee statement on worldwide priorities for hematopoietic transplantation and cellular therapy

  • By

  • Arnon Nagler

  • Norbert Claude Gorin

  • Christian Chabannon

  • Guillermo Puigventós

  • Romée Heemskerk

  • Isabel Sánchez-Ortega

  • Tuula Rintala

  • Yann Mahé

  • Emanuele Angelucci

  • Silvia Montoto

  • Michelle Kenyon

  • Hilda Mekelenkamp

  • Donal P. McLornan

  • Antonio M. Risitano

  • Mette Hazenberg

  • Anna Sureda

  • Ibrahim Yakoub Agha

  • Annalisa Ruggeri

  • Fabio Ciceri

  • Raffaella Greco

  • October 12, 2026

Share

Clinical Scorecard: Correction: EBMT Global Committee statement on worldwide priorities for hematopoietic transplantation and cellular therapy

At a Glance

CategoryDetail
ConditionHematopoietic transplantation and cellular therapy
Key MechanismsNot applicable; the correction adds wording to the Methods section about approval and compliance.
Target PopulationNot specified in the correction notice.
Care SettingNot specified; the correction concerns wording in the Methods section of an EBMT statement.

Key Highlights

  • The correction was published online on 11 August 2026.
  • It concerns the article in Bone Marrow Transplantation, DOI 10.1038/s41409-026-03008-7.
  • Wording was added to paragraph four of the Methods section about approval by the EBMT Board of Directors and compliance with relevant requirements.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          The correction notice does not specify a patient population.

          The correction notice provides no patient-level prescribing or treatment recommendations.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Publisher Correction: defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from the EBMT global committee

            • by Arnon Nagler, Norbert Claude Gorin, Christian Chabannon, Guillermo Puigventós, Romée Heemskerk, Isabel Sánchez-Ortega, Tuula Rintala, Yann Mahé, Emanuele Angelucci, Silvia Montoto, Michelle Kenyon, Hilda Mekelenkamp, Donal P. McLornan, Antonio M. Risitano, Mette Hazenberg, Anna Sureda, Ibrahim Yakoub Agha, Annalisa Ruggeri, Fabio Ciceri, Raffaella Greco

            • October 12, 2026

            Related Content

            Comment on “EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation”

            Glucagon-like peptide-1 receptor agonists and risk for hematologic malignancies: a multicenter propensity score-matched analysis

            Learning curve of robotic pancreaticoduodenectomy: a CUSUM and risk-adjusted CUSUM analysis of 120 consecutive cases